Sign Out
Post-Marketing Experience: The following adverse reactions have been identified during post-approval use of Ticagrelor. Because these reactions are reported voluntarily from a population of an unknown size, it is not always possible to reliably estimate their frequency.
Immune system disorders: Hypersensitivity reactions including angioedema.
Skin and subcutaneous tissue disorders: Rash.
View ADR Reporting Link
Continue with Google